Squire Sanders Pharmaceutical won private Gangster Yan Yan notoriously strong settled again before announcement said Mauritius (China Investment) Limited and TQM Investment Limited the NVC, chairman Yan Yan's Fund SAIF three year John-medicine four times both underweight.
Squire Sanders Pharmaceutical prospectus information SAIF three and TQM are wholly-owned company of SAIF Partners III LP, which is controlled by the sole general partner and management, the general partner is owned holding enterprises Andrew Y. Yan. 2008, SAIF three has spent 60 million yuan shares Squire Sanders Pharmaceutical TQM subsequent 2009 invested 22 million yuan to intervene Squire Sanders Pharmaceutical Squire Sanders Pharmaceutical listed last year, the two funds were to become Squire Sanders Pharmaceutical third and the sixth-largest shareholder, stake up to 18.36%. It is worth mentioning that Shenzhen Capital Group shares shares Squire Sanders Pharmaceutical SAIF three year cost SAIF three nearly 30% higher.
Not difficult to see to SAIF three foreign strategic investors, such as critical for Squire Sanders Pharmaceutical, when the industry is also generally believed that the private equity bigwigs of Yan Yan Shigekura Squire Sanders Pharmaceutical significant. Andrew Y. Yan is clearly not stick the Squire Sanders Pharmaceutical, SAIF three and TQM after the lifting of the ban in April of this year, we can not wait to continuous reduction of Squire Sanders Pharmaceutical. Holdings place from May 21 to May 31, SAIF III, TQM large transactions holdings of 160 million shares, 40 million shares for the first time this year. Subsequently, the two funds were in June and again in August three shots, four times the cumulative reduction of nearly 10 million shares, cash of 159 million yuan, about twice its shares cost.
Squire Sanders Pharmaceutical securities Affairs said a staff member surnamed Wang, the securities Times reporter Yan Yan Department Fund is a private equity investment fund, investing primarily in a market, so four holdings are normal investment behavior, and Squire Sanders Pharmaceutical operations unrelated company now everything is normal. When a reporter asked Yan Yan Department Fund frequent holdings with the NVC Lighting executives bucket regarding the existence of the association and later it will continue to reduce Squire Sanders Pharmaceutical, the staff said that knowledge.
Quite a coincidence, Yan Yan with NVC Lighting founder Wu Changjiang, infighting upgrade began in May of this year, Wu Changjiang resigned from NVC Lighting in late May. The three fund SAIF holdings of Squire Sanders Pharmaceutical Also in May, can not help but lead to the conjecture. In during NVC infighting, NVC Lighting shares continued to slump, Yan Yan's Softbank Investment the carrying fuying sharp decline.
"Although there is no evidence that Andrew Y. Yan fund holdings Squire Sanders Pharmaceutical and NVC Lighting, but simply a normal investment to explain the continuous reduction obviously a bit far-fetched. ZTE (000063) last year, 14 times in a row reduction of national technology (300,077 researcher), has also been understood as the the normal industrial capital investment, but in fact, the ZTE last year's cash flow is very tight, reduction of the national technology just to fill some of the funding gap "the Beijing the banyan investment management Co., a summer family name told reporters.
The reporter also noted that the the recent frequently listed companies of the Pharmaceutical industry capital, fund holdings, such as Gloria Pharmaceuticals, * ST Sinopharm, Kunming Pharmaceutical PETN Church. However, the study of the First Capital securities believes that the favorable policies of the new version of the Essential Drugs List is expected to be introduced in the near future will continue to support the valuation of the pharmaceutical industry.